GORE VIABAHN? ENDOPROSTHESIS - 3 JHJR051002J

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2020-02-11 for GORE VIABAHN? ENDOPROSTHESIS - 3 JHJR051002J manufactured by W.l. Gore & Associates.

Event Text Entries

[187923555] (b)(4). The device was returned to w. L. Gore & associates for investigation. The following observations were made: the delivery catheter, deployment knob, and deployment line were returned. The deployment line was returned in two sections and appeared to be broken. One section was still attached to the deployment knob and measured 150cm including a 1. 2cm single fiber on the end. Approximately 37. 7cm and 141. 3cm from the deployment knob, there were two knots in this section of deployment line. The second section measured approximately 82. 5cm including two single fibers on one end measuring 59. 2cm and 70. 7cm. There was a knot in the single fibers approximately 47. 1cm from the end. The remainder of the device appeared unremarkable. Based on the device evaluation performed, no manufacturing anomalies were identified to which the event could be definitively attributed. Engineering evaluation conclusion is inconclusive as it relates to the event description. The reported issue codes are representative of this event. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[187923556] On (b)(6) 2020, the patient underwent an endovascular treatment for thoracic aortic dissection using gore? Tag? Conformable thoracic stent graft with active control system (ctag-ac), gore? Excluder? Aaa endoprosthesis, and gore? Viabahn? Endoprosthesis with heparin bioactive surface (viabahn). The ctag-ac was reportedly placed below the left subclavian artery. Next the gore? Excluder? Aaa endoprosthesis was inserted into the abdominal aorta and a viabahn was inserted into the left renal artery. It was reported during deployment the viabahn deployed approximately 2cm and resistance was encountered. The physician reportedly continued pulling the deployment line with strong force. It was reported the deployment line broke and became separated from the device. The physicians suspected cause of the deployment line breaking is unknown. It was noted that the viabahn was not fully expanded with approximately 2cm of the stent graft un-deployed. A balloon catheter was inserted and inflated to fully expand the device. It was reportedly noted that the deployment line still attached to the delivery catheter was about 60cm in length. The procedure was completed. The patient tolerated the procedure.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2017233-2020-00087
MDR Report Key9694938
Report SourceCOMPANY REPRESENTATIVE
Date Received2020-02-11
Date of Report2020-03-17
Date of Event2020-01-22
Device Manufacturer Date2018-12-11
Date Added to Maude2020-02-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMARCOS AYALA
Manufacturer Street1500 N. 4TH STREET
Manufacturer CityAZ
Manufacturer Phone9285263030
Manufacturer G1MEDICAL ECHO RIDGE B/P
Manufacturer Street3250 W. KILTIE LANE
Manufacturer CityFLAGSTAFF AZ 86005
Manufacturer CountryUS
Manufacturer Postal Code86005
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGORE VIABAHN? ENDOPROSTHESIS - 3
Generic NameNIP
Product CodePFV
Date Received2020-02-11
Returned To Mfg2020-01-28
Catalog NumberJHJR051002J
Lot Number20175973
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerW.L. GORE & ASSOCIATES
Manufacturer AddressFLAGSTAFF AZ


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2020-02-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.